Candidates will be combining expertise in hematopoietic cell transplant and non-transplant therapy for patients with hematologic malignancies. Development of novel therapy through clinical trials and correlative studies are expected. New faculty will be members of a large, active academic division with the opportunity to participate in a variety of translational and clinical research projects, an NIH-funded training program and an NCI-designated comprehensive cancer center.
Candidates should have training and a career interest in conventional care as well as allogeneic and autologous hematopoietic cell transplant therapy for patients with hematologic malignancies. Applicants should have an M.D. or equivalent degree and board certification or eligibility in Hematology and/or Medical Oncology.
Applicants must have the ability to receive work authorization in the United States from the U.S. Citizenship and Immigration Services and maintain legal status according to the requirements of VISA category while in the United States.
• M.D. and Board Eligible or Certified in Medical Oncology • Demonstrated excellence in patient care • Demonstrated enthusiasm for medical education and strong teaching skills • Must have or be able to attain a medical license in the state of MN • Must be able to pass credentialing at all applicable sites
Both experienced academicians and fellows are encouraged to apply. Applicants should apply online and include curriculum vitae, summary of research, clinical and education accomplishments and future research and grant plans
Internal Number: 334874
About University of Minnesota, Twin Cities
The University of Minnesota, founded in the belief that all people are enriched by understanding, is dedicated to the advancement of learning and the search for truth; to the sharing of this knowledge through education for a diverse community; and to the application of this knowledge to benefit the people of the state, the nation, and the world.